nummo

JMJ Pharma BV

JMJ Pharma (BV) is a company in Orp-Jauche, active in retail sale of pharmaceutical products, founded in 2021, with 2 employees (full-time equivalents). Financial year 2025: gross margin €167,539, profit €1,900, equity €111,605.

ActiveRetail sale of pharmaceutical products
Compare Pro
Annual accounts 2025 filed on 08/06/2026 · profit €1,900 (-86%)View the figures →Read in plain language

Figures for JMJ Pharma, 2025NBB · abridged format

All figures, sector and health →
Gross margin-4%€167,539Profit for the financial year-86%€1,900Equity+2%€111,605Staff+6%1.8 FTE

Three ratios

How we calculate
▼ 1.38 → 1.37 → 1.26
1.26current assets ÷ short-term debt
Position in the sector with Pro
▲ 10.1% → 12.2% → 13.1%
13.1%equity ÷ total assets
Position in the sector with Pro
▼ 2.3% → 3% → 1.8%
1.8%operating profit ÷ total assets
Position in the sector with Pro

Annual accounts 2025. The sector is recalculated every night.

Full profile

See everything about JMJ Pharma

Health check, financial year in detail, 10 years of history and the board.

Start your free trialUnlimited with Pro, €6 per monthFree until 30 November: everything in Pro. After that your account stays free, with 5 full profiles per month. No card.

What happenedfrom the annual accounts and the CBE

  1. Annual accounts 2025 filed
  2. Annual accounts 2024 filed
  3. Annual accounts 2023 filed
  4. Incorporated as besloten vennootschap

Activities NACE-BEL 2025

Establishments 1

AuditProSanctions and politically exposed persons

Is a director on a sanctions list, or do they share the name of a politically exposed person? You can see it with Nummo Pro. Start your free trial

Publications in the Belgian Official Gazette 1 publication

  • 07/04/2021Incorporation and articlesConstitution (nouvelle personne morale, ouverture succursale, etc...)Deed (pdf)

To the publication → list, timeline or per year

E-invoicing and VAT

Checking… · Peppol network and European VAT register (VIES)
PeppolWorking…
Peppol address
VAT number (VIES)Working…

Read more